Company Filing History:

10 out of 4,770

Merck + Co., Inc.

patents

2 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 1991-2012

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8178546 - Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 (2012-05-15),

2. 7662846 - Selective spirocyclic glucocorticoid receptor modulators (2010-02-16),

3. 7329683 - 11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia (2008-02-12),

4. 5998464 - 4-Oxa and 4-thia steroids (1999-12-07),

5. 5777134 - 4-oxa and 4-thia steriods (1998-07-07),

6. 5710275 - 7.beta.-substituted-4-aza-5.alpha.-androstan-3-ones as (1998-01-20),

7. 5693810 - 17 .beta.-carboxanilides of 4-aza-5.alpha.-androstan-3-ones as (1997-12-02),

8. 5527807 - 7.beta.-substituted-4-aza-5.alpha.-cholestan-3-ones as 5.alpha. (1996-06-18),

9. 5278159 - Aryl ester derivatives of 3-oxo-4-aza-androstane 17-.beta.-carboxylates (1994-01-11),

10. 5196411 - 17.beta.-acyl-3-carboxy-androsta-3,5-dienes as testosterone (1993-03-23),

11. 5091380 - N-monosubstituted adamantyl/norbornanyl 17.beta.-carbamides of (1992-02-25),

12. 5075450 - Intermediates in the synthesis of (1991-12-24),

Title: Gool F Patel: Innovator in Pharmaceutical Chemistry

Introduction

Gool F Patel is a notable inventor based in Califon, NJ (US), recognized for his significant contributions to pharmaceutical chemistry. With a total of 12 patents to his name, Patel has made strides in developing innovative compounds that address various health conditions.

Latest Patents

Patel's latest patents include "Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1." This invention focuses on 2,5-Diaryl-1,2,4-triazole derivatives, which serve as selective inhibitors of the 11β-hydroxysteroid dehydrogenase Type 1 enzyme (11β-HSD-1). These compounds are particularly useful in treating diabetes, hyperglycemia, obesity, insulin resistance, atherosclerosis, dyslipidemia, hyperlipidemia, hypertension, and Metabolic Syndrome. Additionally, he has developed selective spirocyclic glucocorticoid receptor modulators, which are valuable as selective glucocorticoid receptor ligands for treating various autoimmune and inflammatory diseases.

Career Highlights

Throughout his career, Gool F Patel has worked with prominent companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical field.

Collaborations

Patel has collaborated with esteemed colleagues, including Gary H Rasmusson and Richard L Tolman. These partnerships have further enhanced his research and innovation capabilities.

Conclusion

Gool F Patel's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to impact the treatment of various health conditions, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.